News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,711 Results
Type
Article (87736)
Company Profile (824)
Press Release (778132)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233166)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91350)
Employer Resources (203)
FDA (18348)
Job Trends (17414)
News (397687)
Policy (39947)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (167)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18439)
Artificial intelligence (577)
Autoimmune disease (129)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (600)
Cancer (4631)
Cardiovascular disease (406)
Career advice (3565)
Career pathing (40)
CAR-T (288)
CDC (59)
Celiac Disease (1)
Cell therapy (781)
Cervical cancer (36)
Clinical research (76477)
Collaboration (1582)
Company closure (5)
Compensation (1055)
Complete response letters (65)
COVID-19 (2974)
CRISPR (93)
C-suite (732)
Cystic fibrosis (147)
Data (5761)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (491)
Diagnostics (7163)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (270)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (222)
Earnings (99875)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134473)
Executive appointments (1009)
FDA (21166)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1429)
Gene editing (201)
Generative AI (60)
Gene therapy (617)
GLP-1 (1081)
Government (5418)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (273)
Immuno-oncology (36)
Indications (76)
Infectious disease (3242)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (216)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (644)
Lymphoma (358)
Machine learning (40)
Management (66)
Manufacturing (736)
MASH (164)
Medical device (14965)
Medtech (15004)
Mergers & acquisitions (22861)
Metabolic disorders (1281)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (321)
Neuropsychiatric disorders (85)
Neuroscience (2943)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (613)
Opinion (326)
Ovarian cancer (152)
Pain (185)
Pancreatic cancer (198)
Parkinson's disease (272)
Partnered (34)
Patents (466)
Patient recruitment (397)
Peanut (58)
People (66614)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23617)
Phase II (33199)
Phase III (25013)
Pipeline (3790)
Policy (318)
Postmarket research (3554)
Preclinical (10659)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (797)
Real estate (7435)
Recruiting (80)
Regulatory (28506)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (234)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1100)
Venture capital (76)
Weight loss (431)
Women's health (76)
Worklife (21)
Date
Today (102)
Last 7 days (650)
Last 30 days (2801)
Last 365 days (33342)
2025 (32247)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (85)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51295)
Australia (9013)
California (10749)
Canada (3154)
China (1043)
Colorado (453)
Connecticut (479)
Delaware (320)
Europe (117932)
Florida (1576)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (886)
India (62)
Indiana (518)
Iowa (22)
Japan (374)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7972)
Michigan (340)
Minnesota (624)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2939)
New Mexico (32)
New York (2879)
North Carolina (1527)
North Dakota (10)
Northern California (5059)
Ohio (327)
Oklahoma (22)
Oregon (52)
Pennsylvania (2181)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4126)
Tennessee (165)
Texas (1688)
United States (39137)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (906)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,711 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurenati Therapeutics Welcomes Dr Daniel Guay to Its Board of Directors and Dr Carlo Di Lorenzo to Its Scientific and Clinical Advisory Board
December 12, 2025
·
2 min read
Press Releases
Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
December 12, 2025
·
4 min read
Press Releases
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb’s Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
December 12, 2025
·
19 min read
Press Releases
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
December 12, 2025
·
4 min read
Press Releases
Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells
December 12, 2025
·
4 min read
Press Releases
NCCN Awards Grants to Improve Care for People with Metastatic Breast Cancer (mBC)
December 12, 2025
·
4 min read
Press Releases
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
December 12, 2025
·
4 min read
Press Releases
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
December 12, 2025
·
7 min read
Press Releases
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
December 12, 2025
·
6 min read
Press Releases
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
December 12, 2025
·
6 min read
1 of 86,672
Next
